ProQR Therapeutics (PRQR) Return on Capital Employed [ROCE] (2014 - 2026)
ProQR Therapeutics (PRQR) reported Return on Capital Employed [ROCE] of -52.62% for the quarter ended Jun 30, 2026, down 14.68 percentage points from -37.94% a year earlier but up 12.34 percentage points from the prior quarter.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, ProQR Therapeutics posted Return on Capital Employed [ROCE] of -41.62%, down 14.89 percentage points from the prior year.
- Return on Capital Employed [ROCE] has a five-year change of +2.19 percentage points (years ended Dec 2020 to Dec 2025).
- By year, Return on Capital Employed [ROCE] came in at -26.73% in the year ended Dec 31, 2024 (+0.22 pp), -26.95% in the year ended Dec 31, 2023 (+8.78 pp), -35.74% in the year ended Dec 31, 2022 (+10.10 pp) and -45.83% in the year ended Dec 31, 2021 (-2.02 pp).
- Five-year quarterly Return on Capital Employed [ROCE] spans a low of -64.96% in the quarter ended Mar 31, 2026 and a high of -26.56% in the quarter ended Mar 31, 2025.
- Year over year, Return on Capital Employed [ROCE] has now declined in each of the last five quarters, with an average year-over-year change of -10.85 percentage points over the last eight quarters.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was the quarter ended Sep 30, 2023 (a gain of 27.09 percentage points); the low point was the quarter ended Mar 31, 2026 (a drop of 38.40 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -64.96% (quarter ended Mar 31, 2026), -48.76% (quarter ended Dec 31, 2025) and -44.02% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | ProQR Therapeutics | 138.02 Mn | -322.63 Mn | - | -53.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.67% |
| Mar 31, 2026 | -64.77% |
| Dec 31, 2025 | -48.51% |
| Sep 30, 2025 | -42.89% |
| Jun 30, 2025 | -36.78% |
| Mar 31, 2025 | -26.77% |
| Dec 31, 2024 | -30.96% |
| Sep 30, 2024 | -36.85% |
| Jun 30, 2024 | -30.44% |
| Mar 31, 2024 | -31.28% |
| Dec 31, 2023 | -30.37% |
| Sep 30, 2023 | -31.76% |
| Jun 30, 2023 | -36.99% |
| Mar 31, 2023 | -37.59% |
| Dec 31, 2022 | -53.37% |
| Sep 30, 2022 | -59.79% |
| Jun 30, 2022 | -42.61% |
| Mar 31, 2022 | -36.30% |
| Dec 31, 2021 | -33.62% |
| Sep 30, 2021 | -36.29% |
API Access
ProQR Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();